trimetazidine has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Celik, A; Demiryürek, AT; Demiryürek, S; Kara, AF; Tarakçioğlu, M | 1 |
Chibisov, SM; Kairakina, TN; Kotliarov, AA; Kulikov, SI; Mosina, LM | 1 |
Cobos, MA; Dueñas, A; Herreros, V; Pérez-Castrillon, JL | 1 |
3 other study(ies) available for trimetazidine and Atrioventricular Nodal Re-Entrant Tachycardia
Article | Year |
---|---|
Effects of chronic trimetazidine treatment on myocardial preconditioning in anesthetized rats.
Topics: Animals; Blood Pressure; Carbachol; Cardiotonic Agents; Heart Rate; Ischemic Preconditioning, Myocardial; Lactic Acid; Male; Malondialdehyde; Myocardial Infarction; Rats; Rats, Wistar; Tachycardia, Ventricular; Trimetazidine; Vasodilator Agents; Ventricular Fibrillation | 2006 |
[The efficacy of complex therapy of ventricular arrhythmias with emoxipin and preductal in combination with antiarrhythmic agents].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Picolines; Tachycardia, Ventricular; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2007 |
Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug.
Topics: Administration, Inhalation; Adult; Aluminum Compounds; Electrocardiography; Emergencies; Humans; Male; Occupational Diseases; Phosphines; Poisoning; Tachycardia, Ventricular; Trimetazidine; Vasodilator Agents | 1999 |